Results 211 to 220 of about 910,981 (387)

Think highly of immunoglobulin G4‐related chronic rhinosinusitis as a clinical entity in immunoglobulin G4‐related disease

open access: yesEye &ENT Research, EarlyView.
Abstract IgG4‐related chronic rhinosinusitis (IgG4‐related CRS) is gaining recognition among various specialized physicians. As a systemic disease involving multiple organs, IgG4‐related CRS is still not widely recognized as an independent clinical entity. Given the complexity of diagnosing autoimmune‐related multisystem diseases, early recognition and
Lianqi Wan   +3 more
wiley   +1 more source

Nosocomial lower respiratory tract infections in patients with immunosuppression: a cohort study. [PDF]

open access: yesAnn Intensive Care
Reyes LF   +38 more
europepmc   +1 more source

Deletion of epithelial HKDC1 decelerates cellular proliferation and impairs mitochondrial function of tumorous epithelial cells thereby protecting from intestinal carcinogenesis

open access: yes
Cancer Communications, EarlyView.
Lea Järke   +15 more
wiley   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Editorial for Special Issue "Antimicrobial Treatment of Lower Respiratory Tract Infections". [PDF]

open access: yesAntibiotics (Basel)
Moschopoulos CD   +3 more
europepmc   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Systematic Review of Factors Associated with Antibiotic Prescribing for Respiratory Tract Infections

open access: yesAntimicrobial Agents and Chemotherapy, 2016
R. McKay   +4 more
semanticscholar   +1 more source

Microbiological aetiology of paediatric respiratory tract infections in Kyrgyzstan. [PDF]

open access: yesBMC Infect Dis
Osmonbaeva N   +19 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy